Data Sharing and Transparency Policy

Data Sharing and Transparency Policy – Journal of Advanced Homoeopathic Studies (JAHS)

The Journal of Advanced Homoeopathic Studies (JAHS) is committed to promoting openness, reproducibility, and accountability in scientific research. We encourage authors to share their data, methods, and supporting materials to strengthen the transparency and reliability of published work.

1. Principles of Data Sharing

  • Authors are encouraged to make research data available to the public whenever ethically and legally permissible.

  • Data includes (but is not limited to): raw datasets, statistical analyses, case records (de-identified), software/code, images, and protocols used in the study.

  • Shared data should allow other researchers to verify findings, replicate analyses, and build upon the work.

2. Authors’ Responsibilities

  • Authors must include a Data Availability Statement in every manuscript, specifying:

    • Whether data are openly available, restricted, or not available.

    • Repository details (if data are deposited).

    • Any conditions for access.

  • Authors must ensure that shared data comply with ethical standards, especially concerning patient confidentiality and informed consent.

  • Clinical trial authors must provide access to trial protocols and anonymized datasets in accordance with ICMJE guidelines.

3. Acceptable Data Repositories

JAHS recommends deposition of datasets in recognized, publicly accessible repositories, such as:

  • Institutional repositories (university/medical college databases).

  • General repositories: Zenodo, Figshare, Dryad, Open Science Framework (OSF).

  • Subject-specific repositories: ClinicalTrials.gov, CTRI (India), PubChem, GenBank, etc.

  • Journal’s supplementary material section (if repository use is not feasible).

4. Data Availability Statement (Examples)

Authors must include one of the following statements in their manuscript:

  • Openly Available: “The datasets generated during and/or analyzed during the current study are available in [repository name], at [DOI or URL].”

  • Available on Request: “The datasets are available from the corresponding author on reasonable request.”

  • Not Available (with justification): “The datasets are not publicly available due to [ethical/privacy/legal restrictions].”

5. Transparency in Reporting

  • Authors must follow international reporting standards:

    • CONSORT (Clinical Trials)

    • PRISMA (Systematic Reviews)

    • CARE (Case Reports)

    • STROBE (Observational Studies)

  • Funding sources, study protocols, and potential conflicts of interest must be transparently disclosed.

6. Patient Privacy & Confidentiality

  • Personal identifiers must be removed from all shared datasets.

  • Patient data must be anonymized in compliance with local and international privacy regulations (e.g., ICMR, GDPR, HIPAA where applicable).

  • Informed consent must include provisions for data sharing where possible.

7. Journal Responsibilities

  • JAHS ensures that all published articles include a Data Availability Statement.

  • Articles without sufficient transparency may be subject to revision, correction, or rejection.

  • Any failure to comply with data-sharing commitments may lead to editorial investigation or retraction, following COPE guidelines.

8. Alignment with International Standards

This policy follows:

  • ICMJE Statement on Data Sharing

  • COPE Principles of Transparency

  • FAIR Data Principles (Findable, Accessible, Interoperable, Reusable)

  • DOAJ Best Practice Guidelines

  • Scopus and PubMed indexing requirements